Listen to “IT MAY SURPRISE YOU TO LEARN THAT EACH YEAR, TENS OF THOUSANDS OF PEOPLE IN THIS COUNTRY ARE DIAGNOSED WITH HIV. WORLDWIDE, ROUGHLY 39-” on Spreaker.
IT MAY SURPRISE YOU TO LEARN THAT EACH YEAR, TENS OF THOUSANDS OF PEOPLE IN THIS COUNTRY ARE DIAGNOSED WITH HIV. WORLDWIDE, ROUGHLY 39-MILLION PEOPLE LIVE WITH THE DISEASE. RESEARCHERS AND SCIENTISTS STUDYING HIV RECENTLY ATTENDED A GLOBAL SUMMIT TO SHARE THEIR LATEST FINDINGS, INCLUDING NEW INTERIM CLINICAL DATA SUGGESTING THE BENEFITS OF LONG-ACTING THERAPY FOR PEOPLE WHO STRUGGLE WITH TAKING DAILY PILLS.
HERE TO TALK ABOUT THESE IMPORTANT FINDINGS AND HOW THEY MAY HELP ADDRESS AN ONGOING AND UNMET NEED IN THE HIV COMMUNITY IS DR. HARMONY GARGES (GAR-JES), CHIEF MEDICAL OFFICER FROM ViiV (VEEV) HEALTHCARE.
BIO:
Dr. Harmony Garges is the Chief Medical Officer at ViiV Healthcare – the only pharmaceutical company 100% dedicated to HIV – where she is responsible for Regulatory, Safety and Medical Affairs across the company’s innovative pipeline and portfolio. Just like the company she works for, Harmony’s guiding mission is to ensure that no person living with HIV is left behind.
After obtaining her MD degree and completing her pediatrics residency at Duke University, Harmony pursued her interest in infectious diseases further with fellowships in Pediatric Infectious Diseases and Medical Microbiology at Duke, along with her MPH in Epidemiology from the University of North Carolina at Chapel Hill. Following her training, Harmony maintained an active clinical practice, providing care to children and adolescents living with HIV and other infectious diseases.
In 2005, Harmony joined GSK’s HIV program in the Infectious Diseases group, working on global development programs as a project physician leader. In this role she oversaw three successful New Drug and Marketing Authorization Applications and provided medical leadership and strategy for the development of various other anti-infectives including the first human trials of dolutegravir – the most prescribed HIV medicine in the world.
Subsequently, Harmony joined the Global Clinical Safety and Pharmacovigilance team at GSK, where she provided safety strategy and governance for several large global clinical development programs in the pharmaceutical space. She then led a large, global team overseeing the safety aspects of GSK’s large Classic and Established Medicines portfolio. From there, she joined the GSK Consumer Health business, where she spent three years as the Chief Medical Officer. She then joined ViiV Healthcare in 2016 and has held several roles in Global Medical Affairs before assuming her current role of Chief Medical Officer at the company in 2019.
#hiv #disease #aids #clinicaldata #dailypills #viiv #drharmonygarges #cabenuva #healthcare #medicalofficer #infectiousdiseases
